Nav: Home

HIV therapy could be contributing to syphilis outbreak: UBC study

January 16, 2017

Drugs used to treat HIV could affect how the body responds to syphilis, inadvertently contributing to a current outbreak, a new study suggests.

Syphilis cases in several countries have risen sharply in recent years, primarily affecting men who have sex with men. In this study, researchers investigating the outbreak hypothesize that medications used in highly active antiretroviral therapy (HAART), the gold standard for treating HIV infection, could reduce the body's immune responses to particular diseases, including syphilis.

"After reading about the astounding increase in syphilis cases, I also noticed a huge gap between syphilis and other sexually transmitted infections like chlamydia and gonorrhea," said Michael Rekart, lead author and clinical professor in UBC's school of population and public health. "That led me to believe there must be something else going on."

Until now, research and clinical communities have suggested that the outbreak could be a result of more risky sexual behaviour, such as people having sex without condoms, springing from the perception that the risk of HIV infection is low due to the availability and effectiveness of HAART.

However, the study points to evidence showing that many men with HIV do not practice high-risk sexual behaviour and that new syphilis cases are commonly observed in people on HAART. It also suggests there are plausible biological explanations for HAART effects on the body's immune response to certain diseases, says Caroline Cameron, a microbiologist at the University of Victoria who was part of the study team.

Rekart and his colleagues used mathematical modeling to predict syphilis rates based on the premise that risky sexual behaviour was the sole cause, and calculated a rate of increase lower than today's actual rate. When they considered both behaviour changes and possible immunity effects, their model predicted a rate that closely approximated the actual incidence of syphilis in B.C. and several other countries. Researchers have not yet compared data of people on HAART who contract syphilis with those not on HAART who contract the infection to establish a link.

While the findings suggest that researchers and health-care professionals should look more closely at this issue, Rekart said it is vital for people to continue to take their HAART. He said people can use information from this study to make behaviour decisions such as always using condoms and reducing the number of sexual partners.

"HAART drugs are life-saving; syphilis is curable," he said. "HAART drugs bring people with HIV back to a normal state of immunity, they can have a normal life, they don't get most opportunistic infections such as tuberculosis."

As a next step, researchers will need to look more closely at the relationship between HAART and infectious and non-infectious diseases and whether there are specific drugs in the HAART medication cocktail that impair immunity.
-end-
The research was published today in Sexually Transmitted Infections: http://sti.bmj.com/lookup/doi/10.1136/sextrans-2016-052870.

An editorial accompanying the new research was also published today by researchers at Johns Hopkins University School of Medicine, Baltimore: http://sti.bmj.com/lookup/doi/10.1136/sextrans-2016-052940

Note: Michael Rekart is in Beijing and can conduct interviews by Skype but has limited availability because of the time difference; he is available at michael.rekart@ubc.ca. University of Victoria's Caroline Cameron is available at: 250-853-3189 or caroc@uvic.ca.

University of British Columbia

Related Hiv Articles:

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.
The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.
Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.
NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
First ever living donor HIV-to-HIV kidney transplant
For the first time, a person living with HIV has donated a kidney to a transplant recipient also living with HIV.
The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.
Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.
HIV RNA expression inhibitors may restore immune function in HIV-infected individuals
Immune activation and inflammation persist in the majority of treated HIV-infected individuals and is associated with excess risk of mortality and morbidity.
HIV vaccine elicits antibodies in animals that neutralize dozens of HIV strains
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world.
State-of-the-art HIV drug could curb HIV transmission, improve survival in India
An HIV treatment regimen already widely used in North America and Europe would likely increase the life expectancy of people living with HIV in India by nearly three years and reduce the number of new HIV infections by 23 percent with minimal impact on the country's HIV/AIDS budget.
More Hiv News and Hiv Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Risk
Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#541 Wayfinding
These days when we want to know where we are or how to get where we want to go, most of us will pull out a smart phone with a built-in GPS and map app. Some of us old timers might still use an old school paper map from time to time. But we didn't always used to lean so heavily on maps and technology, and in some remote places of the world some people still navigate and wayfind their way without the aid of these tools... and in some cases do better without them. This week, host Rachelle Saunders...
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at Radiolab.org/donate.